STOCK TITAN

KORU Medical Appoints Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

Repro Med Systems, Inc., operating as KORU Medical Systems (NASDAQ: KRMD), announced the appointment of Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs. Mr. Pazdan brings over 16 years of experience from notable companies such as Hillrom and Abbott Laboratories. His expertise in quality and regulatory strategy aims to strengthen KORU Medical's Quality Management System to meet global standards. CEO Linda Tharby emphasized Mr. Pazdan's strategic and operational skills as key assets for the company's growth in meeting biopharmaceutical customer needs.

Positive
  • Appointment of Chris Pazdan enhances leadership in quality assurance and regulatory affairs.
  • Mr. Pazdan's 16 years of experience in the medical technology industry strengthens the team's capabilities.
  • Leadership emphasizes development of a robust Quality Management System to meet evolving global standards.
Negative
  • None.

CHESTER, N.Y.--(BUSINESS WIRE)-- Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of Chris Pazdan as the Company's new Vice President of Quality Assurance and Regulatory Affairs. Mr. Pazdan will be responsible for all quality assurance and regulatory affairs as the Company continues to build out a robust Quality Management System and a regulatory strategy to meet evolving global standards.

"Chris has the right mix of strategic, operational, and corporate quality and regulatory skills to bring to this role at KORU Medical," said Linda Tharby, Chief Executive Officer. "His proven track record of developing and leading strategy, a focus on execution and building strong teams will be a valuable asset to KORU Medical as we advance our quality capabilities to meet the needs of our biopharmaceutical customers and support our growth strategy.

Chris Pazdan joins the KORU Medical team with over 16 years of relevant experience in quality assurance and regulatory affairs within the medical technology industry. Most recently, Mr. Pazdan spent over three years at Hillrom, a global medical technology company, where he held the role of Vice President, Quality Assurance, where he led all quality functions for the largest manufacturing division. He also served as the Vice President, Quality Assurance and Regulatory Affairs, where he was responsible for enterprise-wide Design Assurance, Supplier Quality Assurance, Project Management Office, and Software. Prior to Hillrom, Mr. Pazdan also worked at Abbott Laboratories, Becton Dickinson, Wockhardt and Rexam Pharma. Mr. Pazdan received his bachelor's degree in engineering from the University of Illinois at Urbana-Champaign. He is an ASQ Certified Six Sigma Black Belt, ASQ Certified Quality Engineer, and an ASQ Certified Quality Auditor.

About KORU Medical Systems

KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

Investor Contact:

Greg Chodaczek

347-620-7010

investor@korumedical.com

Source: KORU Medical Systems

FAQ

What was announced in the KORU Medical Systems press release on the appointment of Chris Pazdan?

KORU Medical Systems announced the appointment of Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs.

What experience does Chris Pazdan bring to KORU Medical Systems?

Chris Pazdan has over 16 years of experience in quality assurance and regulatory affairs, including leadership roles at Hillrom and Abbott Laboratories.

How will Chris Pazdan's role impact KORU Medical Systems?

He will be responsible for enhancing the company's Quality Management System and regulatory strategy to meet global standards.

Who is the CEO of KORU Medical Systems and what did they say about Chris Pazdan?

Linda Tharby, the CEO, stated that Chris Pazdan brings strategic and operational skills that will be valuable for the company's growth.

KORU Medical Systems, Inc.

NASDAQ:KRMD

KRMD Rankings

KRMD Latest News

KRMD Stock Data

171.89M
42.95M
6.3%
54.38%
1.06%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
MAHWAH